|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: CURAGEN CORP, 10-Q, 2000-08-09 |
Next: CURAGEN CORP, 10-Q, EX-27, 2000-08-09 |
EXHIBIT 11
CURAGEN CORPORATION AND SUBSIDIARY
COMPUTATION OF NET LOSS PER SHARE
(unaudited)
| Three Months Ended
June 30, |
Six Months Ended
|
|||
| |
|
|||
| 2000
|
1999
|
2000
|
1999
|
|
| |
|
|
|
|
| Net loss before income taxes and minority interest | $(6,612,852)
|
$(5,925,143)
|
$(11,652,347)
|
$(13,132,070)
|
| Income tax benefit | 350,000
|
--
|
350,000
|
--
|
| Minority interest | (18,235)
|
--
|
(18,235)
|
--
|
| |
|
|
|
|
| Net loss | $(6,281,087)
|
$(5,925,143)
|
$(11,320,582)
|
$(13,132,070)
|
| |
|
|
|
|
| Basic and diluted net loss per share | $ (0.16)
|
$ (0.22)
|
$ (0.30)
|
$ (0.49)
|
| |
|
|
|
|
|
Weighted average number of shares used in computing
|
38,514,272
|
26,818,474
|
37,288,515
|
26,839,786
|
| |
|
|
|
|
|
|